googlemarker
Open An Account
Secure With Us
Trade on Mobile

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 97015.54 Face Value (Rs.) : 2 House : Natco
Satco Research
BSE533.75-6.05 (-1.12 %)
PREV CLOSE (Rs.) 539.80
OPEN PRICE (Rs.) 538.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 309089
TODAY'S LOW / HIGH (Rs.)527.50 538.00
52 WK LOW / HIGH (Rs.)482 849
NSE532.95-5.65 (-1.05 %)
PREV CLOSE( Rs. ) 538.60
OPEN PRICE (Rs.) 542.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 532.95 (1871)
VOLUME 161154
TODAY'S LOW / HIGH(Rs.) 527.75 542.00
52 WK LOW / HIGH (Rs.)480 848.3
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1653.44
Dividend Yield(%)
1.17
TTM EPS (Rs.)
36.70
P/E Ratio
14.54
Book Value (Rs.)
193.12
Face Value (Rs.)
2
MCap (Rs. in Mn)
97015.54
Price/Earning (TTM)
12.98
Price/Sales (TTM)
4.88
Price/Book (MRQ)
2.76
PAT Margin (%)
33.11
ROCE (%)
34.58
Incorporation Year : 19-09 1981

Management Info :

V C Nannapaneni - Chairman V C Nannapaneni - Managing Director

Registered Office :

Address : Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone : 040-23547532

Registrars Details :

Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX
14Jun Disclosure Under Regulation 30.Of The
Disclosure under Regulation 30.of the SEBI (Listing Obligations and Disc..
13Jun CX Securities divests majority stake i
CX Securities has divested majority of its investment in Natco Pharma, o..
10Jun Natco Pharma expects India, Brazil, Ca
Natco Pharma is expecting India, Brazil and Canada markets to be its rev..
QTR Mar 19 ANNUAL 19
Net Profit12346671
Gross Profit 1544 8474
Operating Profit 1809 9463
Net Sales 4163 19863
Rs. in Millions
Sanofi India (BSE)
img  5429.90 (0.49%)
M.Cap (Rs. in Cr)12505.40
Alkem Laboratories (BSE)
img  1813.55 (0.94%)
M.Cap (Rs. in Cr)21683.71
Wintac (BSE)
img  200.00 (4.82%)
M.Cap (Rs. in Cr)200.48
Themis Medicare (BSE)
img  265.00 (2.81%)
M.Cap (Rs. in Cr)243.29
PROMOTERS
48.71%
NON-INSTITUTION
22.77%
MUTUAL FUNDS/UTI
5.89%
FI/BANKS/INSURANCE
0.99%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     1566159